Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Journal of Otolaryngology - Head & Neck Surgery = Le Journal D'Oto-Rhino-Laryngologie Et De Chirurgie Cervico-Faciale|March 31, 2026
Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal MelanomaQiuyue Ding, Junwan Wu, Ya Ding, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 23, 2024
Exosomal miRNA-26b-5p from PRP suppresses NETs by targeting MMP-8 to promote diabetic wound healingShunli Rui, Linrui Dai, Xiaoshi Zhang, et al.
Thoracic Cancer|January 30, 2020
Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinomaXiaoshi Zhang, Jingyi Han, Lutao Du, et al.
The Journal of Clinical Investigation|April 4, 2023
Long noncoding RNA HITT coordinates with RGS2 to inhibit PD-L1 translation in T cell immunityQingyu Lin, Tong Liu, Xingwen Wang, et al.
Journal for Immunotherapy of Cancer|September 20, 2022
T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancerHuanhe Ni, Huanling Zhang, Lin Li, et al.
Burns & Trauma|November 11, 2025
Peroxisome proliferator-activated receptors-mediated diabetic wound healing regulates endothelial cells' mitochondrial function via sonic hedgehog signalingShunli Rui, Fugang Xiao, Qin Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2020
Safety, Efficacy, and Biomarker Analysis of Toripalimab in Previously Treated Advanced Melanoma: Results of the POLARIS-01 Multicenter Phase II TrialBixia Tang, Zhihong Chi, Yingbo Chen, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2020
Cryoablation combined with transarterial infusion of pembrolizumab (CATAP) for liver metastases of melanoma: an ambispective, proof-of-concept cohort studyLujun Shen, Han Qi, Shuanggang Chen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 28, 2022
B2M and JAK1/2-mutated MSI-H Colorectal Carcinomas Can Benefit From Anti-PD-1 TherapyChenzhi Zhang, Dandan Li, Binyi Xiao, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2020
Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanomaLu Si, Xiaoshi Zhang, Sang Joon Shin, et al.
Pageof 9